| Cover | Apr. 29, 2022 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Apr. 29, 2022 |
| Entity File Number | 001-38803 |
| Entity Registrant Name | Hoth Therapeutics, Inc. |
| Entity Central Index Key | 0001711786 |
| Entity Tax Identification Number | 82-1553794 |
| Entity Incorporation, State or Country Code | NV |
| Entity Address, Address Line One | 1 Rockefeller Plaza |
| Entity Address, Address Line Two | Suite 1039 |
| Entity Address, City or Town | New York |
| Entity Address, State or Province | NY |
| Entity Address, Postal Zip Code | 10020 |
| City Area Code | 646 |
| Local Phone Number | 756-2997 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common stock, $0.0001 par value |
| Trading Symbol | HOTH |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
